Vanda Pharmaceuticals resolves patent litigation with MSN Pharmaceuticals, allowing the latter to produce a generic version of HETLIOZ.
| Name | Vanda Pharmaceuticals Inc. |
|---|---|
| CIK | 0001347178 |
| Tickers | VNDA |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Accelerated filer |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 030491827 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 202-734-3400 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Vanda Pharmaceuticals resolves patent litigation with MSN Pharmaceuticals, allowing the latter to produce a generic version of HETLIOZ.
AQR Capital Management has disclosed a 3.47% stake in Vanda Pharmaceuticals, signaling investment interest in the pharmaceutical sector.
State Street Corporation reveals a 5% ownership stake in Vanda Pharmaceuticals, indicating increased interest in the pharmaceutical preparations sector.
Vanda Pharmaceuticals Inc. reveals its Q3 2026 financial results, highlighting key metrics and ongoing challenges in the pharmaceutical sector.
1339 filing rows loaded from submissions recent; extra archives: CIK0001347178-submissions-001.json (337 filings, 2005-12-29 to 2009-07-11).
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | 8-K | 8-K | 1.01 | 0001628280-26-075166 | 001-34186 | 261576670 | 34 | 152198 | 1 | 1 |
| 2026-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001167557-26-000261 | 005-82196 | 261549356 | 34 | 8982 | |||
| 2026-11-10 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000093751-26-000739 | 005-82196 | 261538388 | 34 | 8073 | |||
| 2026-11-05 | 4 | 4 | 0001193125-26-449902 | 8820 | ||||||
| 2026-10-29 | 10-Q | 10-Q | 0001347178-26-000002 | 001-34186 | 261497587 | 34 | 7150578 | 1 | 1 | |
| 2026-10-28 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-067886 | 001-34186 | 261495793 | 34 | 371875 | 1 | 1 |
| 2026-10-27 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002052113-26-001132 | 005-82196 | 261490543 | 34 | 10949 | |||
| 2026-10-09 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-115112 | 005-82196 | 261453795 | 34 | 19968 | |||
| 2026-08-19 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-098866 | 005-82196 | 261296757 | 34 | 15273 | |||
| 2026-08-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001167557-26-000170 | 005-82196 | 261270621 | 34 | 8790 | |||
| 2026-08-06 | 10-Q | 10-Q | 0001628280-26-053855 | 001-34186 | 261246041 | 34 | 7168445 | 1 | 1 | |
| 2026-08-05 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-053308 | 001-34186 | 261243321 | 34 | 382093 | 1 | 1 |
| 2026-06-08 | 4 | 4 | 0001193125-26-261871 | 5040 | ||||||
| 2026-06-08 | 4 | 4 | 0001193125-26-261811 | 4864 | ||||||
| 2026-06-08 | 4 | 4 | 0001193125-26-261806 | 4821 | ||||||
| 2026-06-08 | 4 | 4 | 0001193125-26-261800 | 4792 | ||||||
| 2026-06-08 | 4 | 4 | 0001193125-26-261790 | 4904 | ||||||
| 2026-06-08 | 4 | 4 | 0001193125-26-261782 | 4881 | ||||||
| 2026-06-08 | 4 | 4 | 0001193125-26-261768 | 4906 | ||||||
| 2026-06-08 | 3 | 3 | 0001193125-26-261752 | 6954 | ||||||
| 2026-06-05 | S-8 | S-8 | 0001628280-26-041303 | 333-296555 | 261069899 | 33 | 608396 | 1 | 1 | |
| 2026-06-05 | 8-K | 8-K | 5.07 | 0001628280-26-041298 | 001-34186 | 261069795 | 34 | 166577 | 1 | 1 |
| 2026-05-20 | 4 | 4 | 0001802653-26-000003 | 4683 | ||||||
| 2026-05-12 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000093751-26-000309 | 005-82196 | 26967130 | 34 | 8105 | |||
| 2026-05-07 | 10-Q | 10-Q | 0001628280-26-031667 | 001-34186 | 26950772 | 34 | 6382992 | 1 | 1 | |
| 2026-05-06 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-031241 | 001-34186 | 26948298 | 34 | 339608 | 1 | 1 |
| 2026-05-05 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001496 | 333-293404 | 26945577 | 33 | 1775 | ||
| 2026-04-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002052113-26-000465 | 005-82196 | 26916030 | 34 | 11000 | |||
| 2026-04-24 | CORRESP | filename1.htm | 0001193125-26-177526 | 14472 | ||||||
| 2026-04-24 | 4 | 4 | 0002130896-26-000008 | 4880 | ||||||
| 2026-04-24 | 3 | 3 | 0002130896-26-000006 | 3035 | ||||||
| 2026-04-23 | ARS | ARS | 0001628280-26-026899 | 001-34186 | 26889404 | 34 | 24422064 | |||
| 2026-04-23 | DEFA14A | DEFA14A | 0001628280-26-026896 | 001-34186 | 26889379 | 34 | 375161 | |||
| 2026-04-23 | DEF 14A | DEF 14A | 0001628280-26-026893 | 001-34186 | 26889364 | 34 | 3891161 | 1 | 1 | |
| 2026-04-22 | 8-K | 8-K | 5.02,9.01 | 0001628280-26-026642 | 001-34186 | 26884802 | 34 | 239983 | 1 | 1 |
| 2026-04-13 | 3 | 3 | 0002128392-26-000003 | 9359 | ||||||
| 2026-04-13 | 3 | 3 | 0002128384-26-000003 | 13250 | ||||||
| 2026-04-02 | 8-K | 8-K | 5.02 | 0001628280-26-023222 | 001-34186 | 26834251 | 34 | 144293 | 1 | 1 |
| 2026-03-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-002588 | 005-82196 | 26805167 | 34 | 7215 | |||
| 2026-03-10 | 8-K | 8-K | 7.01 | 0001628280-26-016516 | 001-34186 | 26740054 | 34 | 146258 | 1 | 1 |
| 2026-03-04 | 4 | 4 | 0001748392-26-000002 | 5373 | ||||||
| 2026-03-04 | 4 | 4 | 0001806596-26-000002 | 6061 | ||||||
| 2026-03-04 | 4 | 4 | 0001785888-26-000002 | 5345 | ||||||
| 2026-03-04 | 4 | 4 | 0001355537-26-000002 | 5407 | ||||||
| 2026-03-04 | 4 | 4 | 0001702031-26-000002 | 5342 | ||||||
| 2026-03-02 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-086369 | 001-34186 | 26710873 | 33 | 4306 | |||
| 2026-03-02 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-086349 | 001-34186 | 26710822 | 33 | 4343 | |||
| 2026-03-02 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-086325 | 001-34186 | 26710796 | 33 | 4347 | |||
| 2026-03-02 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-086321 | 001-34186 | 26710788 | 33 | 4407 | |||
| 2026-03-02 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-086301 | 001-34186 | 26710757 | 33 | 4362 | |||
| 2026-02-24 | 4 | 4 | 0001193125-26-067185 | 4366 | ||||||
| 2026-02-23 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-064742 | 001-34186 | 26667107 | 33 | 5363 | |||
| 2026-02-23 | 8-K | 8-K | 8.01,9.01 | 0001628280-26-010376 | 001-34186 | 26662040 | 34 | 273755 | 1 | 1 |
| 2026-02-19 | 4 | 4 | 0001193125-26-059792 | 4986 | ||||||
| 2026-02-19 | 4 | 4 | 0001193125-26-059784 | 4983 | ||||||
| 2026-02-19 | 4 | 4 | 0001193125-26-059781 | 5014 | ||||||
| 2026-02-19 | 4 | 4 | 0001193125-26-059778 | 5701 | ||||||
| 2026-02-19 | 4 | 4 | 0001193125-26-059770 | 5047 | ||||||
| 2026-02-19 | 8-K | 8-K | 5.02,9.01 | 0001628280-26-009805 | 001-34186 | 26654944 | 34 | 222726 | 1 | 1 |
| 2026-02-18 | UPLOAD | filename1.pdf | 0000000000-26-001642 | 333-293404 | 40151 | |||||
| 2026-02-12 | S-3 | S-3 | 0001628280-26-007476 | 333-293404 | 26623402 | 33 | 1184859 | 1 | 1 | |
| 2026-02-12 | 10-K | 10-K | 0001628280-26-007460 | 001-34186 | 26623364 | 34 | 12380344 | 1 | 1 | |
| 2026-02-11 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-007256 | 001-34186 | 26620686 | 34 | 391598 | 1 | 1 |
| 2026-01-21 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-26-000212 | 005-82196 | 26545748 | 34 | 10911 | |||
| 2026-01-09 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-26-002483 | 005-82196 | 26523316 | 34 | 15595 | |||
| 2026-01-08 | 8-K | 8-K | 8.01,9.01 | 0001628280-26-001273 | 001-34186 | 26517344 | 34 | 238973 | 1 | 1 |
| 2025-12-31 | 8-K | 8-K | 8.01,9.01 | 0001628280-25-059155 | 001-34186 | 251615435 | 34 | 251945 | 1 | 1 |
| 2025-12-04 | 8-K | 8-K | 8.01,9.01 | 0001628280-25-055393 | 001-34186 | 251550269 | 34 | 232242 | 1 | 1 |
| 2025-11-28 | 8-K | 8-K | 8.01,9.01 | 0001628280-25-054225 | 001-34186 | 251532391 | 34 | 233043 | 1 | 1 |
| 2025-10-30 | 10-Q | 10-Q | 0001628280-25-047317 | 001-34186 | 251432204 | 34 | 6437958 | 1 | 1 | |
| 2025-10-29 | 8-K | 8-K | 2.02,9.01 | 0001628280-25-047112 | 001-34186 | 251430015 | 34 | 363345 | 1 | 1 |
| 2025-10-01 | 8-K | 8-K | 8.01,9.01 | 0001628280-25-043489 | 001-34186 | 251365484 | 34 | 237107 | 1 | 1 |
| 2025-08-08 | 4 | 4 | 0000950170-25-105819 | 4457 | ||||||
| 2025-07-31 | 10-Q | 10-Q | 0001628280-25-036861 | 001-34186 | 251169655 | 34 | 6385589 | 1 | 1 | |
| 2025-07-31 | 8-K | 8-K | 2.02,9.01 | 0001628280-25-036843 | 001-34186 | 251169443 | 34 | 353702 | 1 | 1 |
| 2025-07-01 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-064754 | 005-82196 | 251096852 | 34 | 15208 | |||
| 2025-06-16 | 4 | 4 | 0000950170-25-087025 | 4961 | ||||||
| 2025-06-13 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-086506 | 001-34186 | 251048420 | 33 | 5351 | |||
| 2025-06-09 | 4 | 4 | 0000950170-25-083890 | 4769 | ||||||
| 2025-06-09 | 4 | 4 | 0000950170-25-083889 | 4727 | ||||||
| 2025-06-09 | 4 | 4 | 0000950170-25-083888 | 4655 | ||||||
| 2025-06-09 | 4 | 4 | 0000950170-25-083885 | 4744 | ||||||
| 2025-06-09 | 4 | 4 | 0000950170-25-083884 | 4768 | ||||||
| 2025-06-05 | S-8 | S-8 | 0001628280-25-029697 | 333-287808 | 251027764 | 33 | 600000 | 1 | 1 | |
| 2025-06-05 | 8-K | 8-K | 5.07 | 0001628280-25-029678 | 001-34186 | 251027591 | 34 | 166461 | 1 | 1 |
| 2025-05-27 | DEFA14A | DEFA14A | 0001628280-25-027698 | 001-34186 | 25984165 | 34 | 32398 | |||
| 2025-05-21 | 4 | 4 | 0000950170-25-076012 | 5821 | ||||||
| 2025-05-19 | 4 | 4 | 0000950170-25-074565 | 5037 | ||||||
| 2025-05-08 | 10-Q | 10-Q | 0001628280-25-023448 | 001-34186 | 25923819 | 34 | 6099212 | 1 | 1 | |
| 2025-05-07 | 8-K | 8-K | 2.02,9.01 | 0001628280-25-023154 | 001-34186 | 25921355 | 34 | 499957 | 1 | 1 |
| 2025-04-25 | ARS | ARS | 0001628280-25-019996 | 001-34186 | 25874709 | 34 | 21806270 | |||
| 2025-04-25 | DEFA14A | DEFA14A | 0001628280-25-019992 | 001-34186 | 25874665 | 34 | 303273 | |||
| 2025-04-25 | DEF 14A | DEF 14A | 0001628280-25-019987 | 001-34186 | 25874625 | 34 | 3582738 | 1 | 1 | |
| 2025-04-15 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-000361 | 005-82196 | 25840350 | 34 | 10754 | |||
| 2025-03-17 | 8-K | 8-K | 7.01 | 0001193125-25-055287 | 001-34186 | 25742586 | 34 | 193741 | 1 | 1 |
| 2025-03-06 | 4 | 4 | 0000950170-25-034966 | 5830 | ||||||
| 2025-03-05 | 4 | 4 | 0000950170-25-033845 | 5830 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032285 | 4742 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032281 | 4739 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032276 | 6718 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032273 | 5459 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032270 | 4770 | ||||||
| 2025-02-28 | 4 | 4 | 0000950170-25-030176 | 4463 | ||||||
| 2025-02-27 | 4 | 4 | 0000950170-25-029059 | 4463 | ||||||
| 2025-02-26 | 4 | 4 | 0000950170-25-027860 | 5830 | ||||||
| 2025-02-25 | 4 | 4 | 0000950170-25-027056 | 5044 | ||||||
| 2025-02-24 | 4 | 4 | 0000950170-25-025914 | 5118 | ||||||
| 2025-02-20 | 4 | 4 | 0000950170-25-024498 | 4991 | ||||||
| 2025-02-20 | 4 | 4 | 0000950170-25-024489 | 5049 | ||||||
| 2025-02-20 | 4 | 4 | 0000950170-25-024487 | 5706 | ||||||
| 2025-02-20 | 4 | 4 | 0000950170-25-024486 | 4988 | ||||||
| 2025-02-20 | 4 | 4 | 0000950170-25-024485 | 5019 | ||||||
| 2025-02-20 | 8-K | 8-K | 5.02 | 0001193125-25-030780 | 001-34186 | 25646134 | 34 | 203420 | 1 | 1 |
| 2025-02-14 | 10-K | 10-K | 0001628280-25-005761 | 001-34186 | 25629755 | 34 | 11705956 | 1 | 1 | |
| 2025-02-13 | 8-K | 8-K | 2.02,9.01 | 0001628280-25-005406 | 001-34186 | 25620265 | 34 | 434010 | 1 | 1 |
| 2025-02-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-000166 | 005-82196 | 25600797 | 34 | 11088 | |||
| 2025-02-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-001341 | 005-82196 | 25592310 | 34 | 11955 | |||
| 2025-01-27 | 8-K | 8-K | 7.01 | 0001193125-25-012740 | 001-34186 | 25555821 | 34 | 185397 | 1 | 1 |
| 2024-11-18 | 4 | 4 | 0000950170-24-128115 | 4970 | ||||||
| 2024-11-14 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-127062 | 001-34186 | 241462218 | 33 | 4344 | |||
| 2024-11-07 | 10-Q | 10-Q | 0001628280-24-045970 | 001-34186 | 241433118 | 34 | 6123323 | 1 | 1 | |
| 2024-11-06 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-045724 | 001-34186 | 241431219 | 34 | 431902 | 1 | 1 |
| 2024-10-15 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-237220 | 001-34186 | 241369324 | 34 | 203739 | 1 | 1 |
| 2024-10-03 | 8-K | 8-K | 5.03,9.01 | 0001193125-24-232306 | 001-34186 | 241352284 | 34 | 397277 | 1 | 1 |
| 2024-09-19 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-221784 | 001-34186 | 241309134 | 34 | 210395 | 1 | 1 |
| 2024-08-08 | 8-A12B/A | 8-A12B/A | 0001193125-24-196495 | 001-34186 | 241186109 | 34 | 19746 | |||
| 2024-08-08 | 8-K | 8-K | 1.01,3.03,9.01 | 0001193125-24-196481 | 001-34186 | 241186054 | 34 | 222578 | 1 | 1 |
| 2024-08-01 | 10-Q | 10-Q | 0001628280-24-033866 | 001-34186 | 241164160 | 34 | 6003077 | 1 | 1 | |
| 2024-07-31 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-033743 | 001-34186 | 241161900 | 34 | 426814 | 1 | 1 |
| 2024-07-29 | 4 | 4 | 0000950170-24-087381 | 5546 | ||||||
| 2024-07-29 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-087370 | 001-34186 | 241153487 | 33 | 4341 | |||
| 2024-06-20 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-164545 | 001-34186 | 241057247 | 34 | 204709 | 1 | 1 |
| 2024-06-13 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-160755 | 001-34186 | 241041785 | 34 | 209382 | 1 | 1 |
| 2024-06-06 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-156117 | 001-34186 | 241025909 | 34 | 222424 | 1 | 1 |
| 2024-05-24 | 8-K | 8-K | 8.01,9.01 | 0001628280-24-025254 | 001-34186 | 24985212 | 34 | 283742 | 1 | 1 |
| 2024-05-24 | 4 | 4 | 0000950170-24-064669 | 7035 | ||||||
| 2024-05-24 | 8-K/A | 8-K/A | 5.07 | 0001628280-24-025241 | 001-34186 | 24984958 | 34 | 216277 | 1 | 1 |
| 2024-05-21 | 4 | 4 | 0000950170-24-063022 | 7052 | ||||||
| 2024-05-21 | 4 | 4 | 0000950170-24-063019 | 6964 | ||||||
| 2024-05-21 | 4 | 4 | 0000950170-24-063017 | 7077 | ||||||
| 2024-05-21 | 4 | 4 | 0000950170-24-063015 | 7076 | ||||||
| 2024-05-21 | S-8 | S-8 | 0001628280-24-024550 | 333-279591 | 24969968 | 33 | 484192 | |||
| 2024-05-20 | 8-K | 8-K | 5.07 | 0001628280-24-024405 | 001-34186 | 24965972 | 34 | 222605 | 1 | 1 |
| 2024-05-13 | DEFA14A | DEFA14A | 0001193125-24-137238 | 001-34186 | 24939276 | 34 | 24925 | |||
| 2024-05-09 | DEFA14A | DEFA14A | 0001193125-24-135393 | 001-34186 | 24931917 | 34 | 822069 | |||
| 2024-05-09 | 10-Q | 10-Q | 0001628280-24-021952 | 001-34186 | 24928514 | 34 | 5735941 | 1 | 1 | |
| 2024-05-08 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-021658 | 001-34186 | 24925872 | 34 | 415737 | 1 | 1 |
| 2024-05-07 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-133252 | 001-34186 | 24922870 | 34 | 192410 | 1 | 1 |
| 2024-05-03 | 8-A12B/A | 8-A12B/A | 0001193125-24-130778 | 001-34186 | 24913539 | 34 | 19404 | |||
| 2024-05-03 | 8-K | 8-K | 1.01,3.03,9.01 | 0001193125-24-130668 | 001-34186 | 24912882 | 34 | 209362 | 1 | 1 |
| 2024-04-29 | ARS/A | AMENDMENT TO ANNUAL REPORT | 0001213900-24-037204 | 001-34186 | 24891439 | 34 | 766263 | |||
| 2024-04-29 | ARS | ANNUAL REPORT | 0001213900-24-036807 | 001-34186 | 24886442 | 34 | 764893 | |||
| 2024-04-29 | DEF 14A | PROXY STATEMENT | 0001213900-24-036802 | 001-34186 | 24886419 | 34 | 12427774 | 1 | 1 | |
| 2024-04-17 | 8-A12B | 8-A12B | 0001193125-24-099263 | 001-34186 | 24852085 | 34 | 34956 | |||
| 2024-04-17 | 8-K | 8-K | 1.01,3.03,5.03,8.01,9.01 | 0001193125-24-099251 | 001-34186 | 24851999 | 34 | 691799 | 1 | 1 |
| 2024-04-03 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-086031 | 001-34186 | 24819296 | 34 | 195639 | 1 | 1 |
| 2024-03-07 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-062241 | 001-34186 | 24730620 | 34 | 158486 | 1 | 1 |
| 2024-03-06 | 4 | 4 | 0000950170-24-027266 | 7340 | ||||||
| 2024-03-06 | 4 | 4 | 0000950170-24-027259 | 7312 | ||||||
| 2024-03-06 | 4 | 4 | 0000950170-24-027256 | 7372 | ||||||
| 2024-03-06 | 4 | 4 | 0000950170-24-027253 | 8026 | ||||||
| 2024-03-06 | 4 | 4 | 0000950170-24-027249 | 7309 | ||||||
| 2024-03-04 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-025255 | 001-34186 | 24717969 | 33 | 4341 | |||
| 2024-03-04 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-025251 | 001-34186 | 24717966 | 33 | 4310 | |||
| 2024-03-04 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-025247 | 001-34186 | 24717959 | 33 | 4449 | |||
| 2024-03-04 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-025245 | 001-34186 | 24717956 | 33 | 4346 | |||
| 2024-03-04 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-025243 | 001-34186 | 24717954 | 33 | 4309 | |||
| 2024-02-21 | 4 | 4 | 0000950170-24-018033 | 5019 | ||||||
| 2024-02-21 | 4 | 4 | 0000950170-24-018032 | 4993 | ||||||
| 2024-02-21 | 4 | 4 | 0000950170-24-018027 | 5706 | ||||||
| 2024-02-21 | 4 | 4 | 0000950170-24-018030 | 5052 | ||||||
| 2024-02-21 | 4 | 4 | 0000950170-24-018024 | 4991 | ||||||
| 2024-02-21 | 8-K | 8-K | 5.02 | 0001193125-24-041514 | 001-34186 | 24660172 | 34 | 157375 | 1 | 1 |
| 2024-02-16 | 8-K/A | 8-K/A | 9.01 | 0001193125-24-038517 | 001-34186 | 24648890 | 34 | 381100 | 1 | 1 |
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-022210 | 005-82196 | 24629790 | 34 | 13097 | |||
| 2024-02-13 | SC 13G/A | vnda-13g_20231231.txt | 0001037389-24-000067 | 005-82196 | 24623431 | 34 | 13466 | |||
| 2024-02-09 | SC 13G/A | SEC SCHEDULE 13G | 0000354204-24-003342 | 005-82196 | 24612572 | 34 | 19505 | |||
| 2024-02-08 | 10-K | 10-K | 0001628280-24-003785 | 001-34186 | 24606853 | 34 | 10739145 | 1 | 1 | |
| 2024-02-07 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-003693 | 001-34186 | 24604329 | 34 | 385216 | 1 | 1 |
| 2024-02-05 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-024112 | 001-34186 | 24596224 | 34 | 161858 | 1 | 1 |
| 2024-01-23 | SC 13G/A | us9216591084_012324.txt | 0001086364-24-001408 | 005-82196 | 24551331 | 34 | 13532 | |||
| 2024-01-22 | SC 13G/A | Vanda_Phar_Inc.txt | 0000093751-24-000046 | 005-82196 | 24547526 | 34 | 8477 | |||
| 2023-12-15 | 8-K | 8-K | 5.03,9.01 | 0001193125-23-296659 | 001-34186 | 231490523 | 34 | 352454 | 1 | 1 |
| 2023-12-07 | 8-K | 8-K | 1.01,2.01,8.01,9.01 | 0001193125-23-290779 | 001-34186 | 231473323 | 34 | 194176 | 1 | 1 |
| 2023-11-09 | 10-Q | 10-Q | 0001628280-23-038029 | 001-34186 | 231390003 | 34 | 5768092 | 1 | 1 | |
| 2023-11-08 | 8-K | 8-K | 2.02,9.01 | 0001628280-23-037827 | 001-34186 | 231387790 | 34 | 358765 | 1 | 1 |
| 2023-10-06 | SC 13G/A | us9216591084_100523.txt | 0001306550-23-010078 | 005-82196 | 231313908 | 34 | 13563 | |||
| 2023-08-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-047056 | 5074 | ||||||
| 2023-08-21 | 8-K | 8-K | 8.01 | 0001193125-23-217063 | 001-34186 | 231189983 | 34 | 142934 | 1 | 1 |
| 2023-08-21 | 144 | xsl144X01/primary_doc.xml | 0001802653-23-000002 | 001-34186 | 231189915 | 33 | 4239 | |||
| 2023-08-11 | 4 | FORM 4 SUBMISSION | 0001209191-23-045447 | 5117 | ||||||
| 2023-08-10 | 144 | xsl144X01/primary_doc.xml | 0001983609-23-000002 | 001-34186 | 231160885 | 33 | 4278 | |||
| 2023-08-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-043990 | 7354 | ||||||
| 2023-07-28 | 144 | xsl144X01/primary_doc.xml | 0001983609-23-000001 | 001-34186 | 231123542 | 33 | 4930 | |||
| 2023-07-28 | 10-Q | 10-Q | 0001628280-23-026000 | 001-34186 | 231120176 | 34 | 5334003 | 1 | 1 | |
| 2023-07-27 | 8-K | 8-K | 2.02,9.01 | 0001628280-23-025916 | 001-34186 | 231118421 | 34 | 360281 | 1 | 1 |
| 2023-06-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-038417 | 5835 | ||||||
| 2023-06-15 | 144 | xsl144X01/primary_doc.xml | 0001730052-23-000002 | 001-34186 | 231018775 | 33 | 8225 | |||
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-037326 | 5149 | ||||||
| 2023-06-13 | 144 | xsl144X01/primary_doc.xml | 0001730052-23-000001 | 001-34186 | 231012733 | 33 | 4272 | |||
| 2023-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-036289 | 7386 | ||||||
| 2023-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-036285 | 7387 | ||||||
| 2023-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-036282 | 7362 | ||||||
| 2023-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-036280 | 7273 | ||||||
| 2023-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-036275 | 7345 | ||||||
| 2023-06-08 | S-8 | S-8 | 0001628280-23-021546 | 333-272522 | 231002599 | 33 | 470870 | |||
| 2023-06-08 | 8-K | 8-K | 5.07 | 0001628280-23-021539 | 001-34186 | 231002516 | 34 | 203274 | 1 | 1 |
| 2023-05-11 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-141366 | 001-34186 | 23908743 | 34 | 178356 | 1 | 1 |
| 2023-05-05 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-05-05 16:30:00 | 9999999995-23-001312 | 333-269654 | 23895716 | 33 | 1733 | ||
| 2023-05-03 | CORRESP | filename1.htm | 0001193125-23-134561 | 10026 | ||||||
| 2023-05-03 | S-3/A | S-3/A | 0001193125-23-134544 | 333-269654 | 23885293 | 33 | 76304 | |||
| 2023-05-03 | 10-Q | 10-Q | 0001628280-23-015267 | 001-34186 | 23885083 | 34 | 5492311 | 1 | 1 | |
| 2023-05-03 | 8-K | 8-K | 2.02,9.01 | 0001628280-23-015206 | 001-34186 | 23883658 | 34 | 355871 | 1 | 1 |
| 2023-04-24 | ARS | ARS | 0001628280-23-012597 | 001-34186 | 23840962 | 34 | 18634343 | |||
| 2023-04-24 | DEFA14A | DEFA14A | 0001628280-23-012596 | 001-34186 | 23840949 | 34 | 819620 | |||
| 2023-04-24 | DEF 14A | DEF 14A | 0001628280-23-012594 | 001-34186 | 23840936 | 34 | 5400310 | 1 | 1 | |
| 2023-03-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-019714 | 7625 | ||||||
| 2023-03-17 | 3 | FORM 3 SUBMISSION | 0001209191-23-019711 | 2969 | ||||||
| 2023-03-17 | 8-K | 8-K | 5.02,9.01 | 0001628280-23-008386 | 001-34186 | 23740656 | 34 | 252613 | 1 | 1 |
| 2023-03-13 | 8-K | 8-K | 7.01 | 0001628280-23-007646 | 001-34186 | 23725964 | 34 | 174585 | 1 | 1 |
| 2023-03-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-016464 | 7708 | ||||||
| 2023-03-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-016463 | 7142 | ||||||
| 2023-03-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-016462 | 7740 | ||||||
| 2023-03-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-016461 | 8398 | ||||||
| 2023-03-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-016460 | 7678 | ||||||
| 2023-02-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-011343 | 7693 | ||||||
| 2023-02-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-011342 | 7665 | ||||||
| 2023-02-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-011341 | 7729 | ||||||
| 2023-02-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-011340 | 8380 | ||||||
| 2023-02-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-011338 | 7663 | ||||||
| 2023-02-17 | 8-K | 8-K | 5.02 | 0001193125-23-042033 | 001-34186 | 23643129 | 34 | 159691 | 1 | 1 |
| 2023-02-16 | UPLOAD | filename1.pdf | 0000000000-23-001606 | 40344 | ||||||
| 2023-02-14 | SC 13G/A | vanda.txt | 0001306923-23-000008 | 005-82196 | 23629875 | 34 | 275522 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001193125-23-038526 | 005-82196 | 23626513 | 34 | 97805 | |||
| 2023-02-13 | SC 13G/A | vnda-13g_20221231.txt | 0001037389-23-000060 | 005-82196 | 23615860 | 34 | 13390 | |||
| 2023-02-10 | SC 13G | SEC SCHEDULE 13G | 0000354204-23-001724 | 005-82196 | 23611072 | 34 | 19414 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-017219 | 005-82196 | 23604482 | 34 | 13015 | |||
| 2023-02-09 | S-3 | S-3 | 0001193125-23-029269 | 333-269654 | 23601230 | 33 | 1565880 | |||
| 2023-02-09 | 10-K | 10-K | 0001628280-23-002857 | 001-34186 | 23601076 | 34 | 10123117 | 1 | 1 | |
| 2023-02-08 | 8-K | 8-K | 2.02,9.01 | 0001628280-23-002764 | 001-34186 | 23599182 | 34 | 377664 | 1 | 1 |
| 2023-02-07 | SC 13G/A | Vanda_Pharmaceuticals_Inc.txt | 0000093751-23-000329 | 005-82196 | 23594462 | 34 | 8504 | |||
| 2023-01-24 | SC 13G/A | us9216591084_012423.txt | 0001306550-23-002977 | 005-82196 | 23547388 | 34 | 13251 | |||
| 2022-12-23 | 8-K | 8-K | 8.01 | 0001193125-22-311271 | 001-34186 | 221483159 | 34 | 143635 | 1 | 1 |
| 2022-12-16 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-307491 | 001-34186 | 221468867 | 34 | 158804 | 1 | 1 |
| 2022-12-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-061673 | 5112 | ||||||
| 2022-12-14 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-304290 | 001-34186 | 221461095 | 34 | 164447 | 1 | 1 |
| 2022-12-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-060227 | 15156 | ||||||
| 2022-12-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-060225 | 10004 | ||||||
| 2022-11-03 | 10-Q | 10-Q | 0001628280-22-027951 | 001-34186 | 221356135 | 34 | 5863160 | 1 | 1 | |
| 2022-11-02 | 8-K | 8-K | 2.02,9.01 | 0001628280-22-027812 | 001-34186 | 221354083 | 34 | 387332 | 1 | 1 |
| 2022-08-29 | 4 | FORM 4 SUBMISSION | 0001209191-22-047887 | 6885 | ||||||
| 2022-08-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-047210 | 5044 | ||||||
| 2022-08-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-046228 | 7134 | ||||||
| 2022-08-04 | 10-Q | 10-Q | 0001628280-22-020848 | 001-34186 | 221134583 | 34 | 5695465 | 1 | 1 | |
| 2022-08-03 | 8-K | 8-K | 2.02,9.01 | 0001628280-22-020607 | 001-34186 | 221132705 | 34 | 383601 | 1 | 1 |
| 2022-08-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-043682 | 5758 | ||||||
| 2022-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-038449 | 7356 | ||||||
| 2022-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-038448 | 7357 | ||||||
| 2022-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-038447 | 7243 | ||||||
| 2022-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-038446 | 7315 | ||||||
| 2022-06-17 | S-8 | S-8 | 0001347178-22-000006 | 333-265692 | 221024043 | 33 | 460744 | |||
| 2022-06-16 | 8-K | 8-K | 5.07 | 0001347178-22-000003 | 001-34186 | 221020785 | 34 | 196383 | 1 | 1 |
| 2022-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-036835 | 5369 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034062 | 9075 | ||||||
| 2022-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-033561 | 9075 | ||||||
| 2022-05-06 | 10-Q | 10-Q | 0001628280-22-012834 | 001-34186 | 22898806 | 34 | 5464558 | 1 | 1 | |
| 2022-05-05 | 8-K | 8-K | 2.02,9.01 | 0001628280-22-012673 | 001-34186 | 22896655 | 34 | 542871 | 1 | 1 |
| 2022-04-25 | DEFA14A | DEFA14A | 0001628280-22-010129 | 001-34186 | 22850129 | 34 | 1186949 | |||
| 2022-04-25 | DEF 14A | DEF 14A | 0001628280-22-010125 | 001-34186 | 22850093 | 34 | 2645053 | |||
| 2022-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-015160 | 10254 | ||||||
| 2022-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-015158 | 10224 | ||||||
| 2022-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-015157 | 11855 | ||||||
| 2022-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-015155 | 12503 | ||||||
| 2022-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-015154 | 11787 | ||||||
| 2022-03-01 | 8-K | 8-K | 5.02 | 0001193125-22-061308 | 001-34186 | 22697957 | 34 | 166189 | 1 | 1 |
| 2022-02-24 | 10-K | 10-K | 0001628280-22-003629 | 001-34186 | 22666470 | 34 | 10815622 | 1 | 1 | |
| 2022-02-23 | 8-K | 8-K | 2.02,9.01 | 0001628280-22-003504 | 001-34186 | 22663641 | 34 | 405703 | 1 | 1 |
| 2022-02-15 | SC 13G/A | SC 13G/A | 0001193125-22-042673 | 005-82196 | 22636873 | 34 | 70457 | |||
| 2022-02-14 | SC 13G/A | vanda.txt | 0001306923-22-000011 | 005-82196 | 22634531 | 34 | 11743 | |||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001193125-22-040407 | 005-82196 | 22627233 | 34 | 114822 | |||
| 2022-02-14 | SC 13G/A | VANDA_PHARMACEUTICALS_INC.txt | 0000093751-22-000360 | 005-82196 | 22624198 | 34 | 8480 | |||
| 2022-02-11 | SC 13G/A | vnda-13g_20211231.txt | 0001037389-22-000203 | 005-82196 | 22620466 | 34 | 13388 | |||
| 2022-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-018821 | 005-82196 | 22611095 | 34 | 13010 | |||
| 2022-02-04 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-027687 | 001-34186 | 22590959 | 34 | 173335 | 1 | 1 |
| 2022-01-27 | SC 13G/A | us9216591084_012722.txt | 0000834237-22-002684 | 005-82196 | 22564285 | 34 | 13275 | |||
| 2022-01-26 | SC 13G/A | us9216591084_012622.txt | 0000834237-22-001286 | 005-82196 | 22556120 | 34 | 13275 | |||
| 2022-01-14 | 8-K | 8-K | 1.01,9.01 | 0001193125-22-009851 | 001-34186 | 22531930 | 34 | 170155 | 1 | 1 |
| 2021-12-02 | 4 | FORM 4 SUBMISSION | 0001209191-21-067592 | 15156 | ||||||
| 2021-11-04 | 10-Q | 10-Q | 0001347178-21-000032 | 001-34186 | 211377974 | 34 | 5780427 | 1 | 1 | |
| 2021-11-03 | 8-K | 8-K | 2.02,9.01 | 0001347178-21-000030 | 001-34186 | 211375392 | 34 | 413625 | 1 | 1 |
| 2021-10-08 | 8-K | 8-K | 5.02 | 0001193125-21-295465 | 001-34186 | 211315389 | 34 | 144115 | 1 | 1 |
| 2021-09-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-056530 | 13501 | ||||||
| 2021-09-13 | 4 | FORM 4 SUBMISSION | 0001209191-21-055685 | 13164 | ||||||
| 2021-08-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-052965 | 5613 | ||||||
| 2021-08-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-051865 | 5641 | ||||||
| 2021-07-30 | 4 | FORM 4 SUBMISSION | 0001209191-21-048738 | 6328 | ||||||
| 2021-07-29 | 10-Q | 10-Q | 0001347178-21-000028 | 001-34186 | 211124770 | 34 | 5680990 | 1 | 1 | |
| 2021-07-28 | 8-K | 8-K | 2.02,9.01 | 0001347178-21-000025 | 001-34186 | 211122613 | 34 | 378258 | 1 | 1 |
| 2021-07-27 | 4 | FORM 4 SUBMISSION | 0001209191-21-048276 | 5617 | ||||||
| 2021-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-041496 | 9487 | ||||||
| 2021-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-040615 | 5539 | ||||||
| 2021-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-040244 | 7244 | ||||||
| 2021-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-040243 | 7356 | ||||||
| 2021-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-040240 | 7357 | ||||||
| 2021-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-040237 | 7243 | ||||||
| 2021-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-040236 | 7315 | ||||||
| 2021-06-10 | S-8 | S-8 | 0001347178-21-000022 | 333-256994 | 211008872 | 33 | 446894 | |||
| 2021-06-10 | 8-K | 8-K | 5.07,8.01 | 0001347178-21-000021 | 001-34186 | 211008820 | 34 | 200450 | 1 | 1 |
| 2021-05-06 | 10-Q | 10-Q | 0001347178-21-000015 | 001-34186 | 21895709 | 34 | 5353841 | 1 | 1 | |
| 2021-05-05 | 8-K | 8-K | 2.02,9.01 | 0001347178-21-000013 | 001-34186 | 21893220 | 34 | 364931 | 1 | 1 |
| 2021-04-22 | DEFA14A | DEFA14A | 0001347178-21-000009 | 001-34186 | 21843237 | 34 | 1003473 | |||
| 2021-04-22 | DEF 14A | DEF 14A | 0001347178-21-000008 | 001-34186 | 21843232 | 34 | 2238907 | |||
| 2021-03-16 | 4 | FORM 4 SUBMISSION | 0001209191-21-020782 | 9466 | ||||||
| 2021-03-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-019118 | 5091 | ||||||
| 2021-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-018651 | 6124 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-017280 | 7705 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-017278 | 5612 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-017276 | 7687 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-017274 | 8430 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-017273 | 5617 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-017272 | 7681 | ||||||
| 2021-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-21-014886 | 7695 | ||||||
| 2021-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-21-014882 | 7666 | ||||||
| 2021-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-21-014878 | 7642 | ||||||
| 2021-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-21-014876 | 8382 | ||||||
| 2021-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-21-014873 | 14054 | ||||||
| 2021-02-26 | 4 | FORM 4 SUBMISSION | 0001209191-21-014869 | 7633 | ||||||
| 2021-02-25 | 8-K | 8-K | 5.02 | 0001193125-21-055675 | 001-34186 | 21676355 | 34 | 161116 | 1 | 1 |
| 2021-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-21-012205 | 9079 | ||||||
| 2021-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-21-012204 | 9078 | ||||||
| 2021-02-16 | SC 13G/A | d8800923_13g-a.htm | 0000919574-21-001697 | 005-82196 | 21640692 | 34 | 94422 | |||
| 2021-02-16 | SC 13G/A | Vanda_13G_A9.txt | 0001306923-21-000020 | 005-82196 | 21640029 | 34 | 276206 | |||
| 2021-02-12 | SC 13G/A | SC 13G/A | 0001193125-21-040098 | 005-82196 | 21622981 | 34 | 127301 | |||
| 2021-02-11 | SC 13G/A | vnda-13g_20201231.txt | 0001037389-21-000317 | 005-82196 | 21618795 | 34 | 13389 | |||
| 2021-02-11 | SC 13G | VandaPharmaceuticalsInc.txt | 0000093751-21-000257 | 005-82196 | 21616901 | 34 | 8421 | |||
| 2021-02-11 | 10-K | 10-K | 0001347178-21-000005 | 001-34186 | 21616644 | 34 | 10864966 | 1 | 1 | |
| 2021-02-10 | 8-K | 8-K | 2.02,9.01 | 0001347178-21-000002 | 001-34186 | 21613841 | 34 | 395643 | 1 | 1 |
| 2021-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-21-019336 | 005-82196 | 21612237 | 34 | 13878 | |||
| 2021-01-25 | SC 13G | us9216591084_012521.txt | 0000834237-21-000440 | 005-82196 | 21550204 | 34 | 13271 | |||
| 2020-12-15 | 4 | FORM 4 SUBMISSION | 0001209191-20-063474 | 20963 | ||||||
| 2020-12-02 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-307818 | 001-34186 | 201362387 | 34 | 170719 | 1 | 1 |
| 2020-10-29 | 10-Q | 10-Q | 0001347178-20-000030 | 001-34186 | 201270436 | 34 | 5839526 | 1 | 1 | |
| 2020-10-28 | 8-K | 8-K | 2.02,9.01 | 0001347178-20-000027 | 001-34186 | 201268673 | 34 | 392458 | 1 | 1 |
| 2020-08-21 | 4 | FORM 4 SUBMISSION | 0001209191-20-047991 | 5614 | ||||||
| 2020-08-18 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-223727 | 001-34186 | 201114600 | 34 | 472000 | 1 | 1 |
| 2020-08-17 | 4 | FORM 4 SUBMISSION | 0001209191-20-046965 | 5641 | ||||||
| 2020-08-14 | 4 | FORM 4 SUBMISSION | 0001209191-20-046804 | 5122 | ||||||
| 2020-08-06 | 10-Q | 10-Q | 0001347178-20-000024 | 001-34186 | 201079736 | 34 | 6502911 | 1 | 1 | |
| 2020-08-05 | 8-K | 8-K | 2.02,9.01 | 0001347178-20-000022 | 001-34186 | 201077259 | 34 | 452338 | 1 | 1 |
| 2020-07-29 | 4 | FORM 4 SUBMISSION | 0001209191-20-043999 | 8369 | ||||||
| 2020-07-29 | 4 | FORM 4 SUBMISSION | 0001209191-20-043998 | 5617 | ||||||
| 2020-07-29 | 8-K | 8-K | 5.02,9.01 | 0001193125-20-202550 | 001-34186 | 201057484 | 34 | 197958 | 1 | 1 |
| 2020-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-20-036787 | 7243 | ||||||
| 2020-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-20-036785 | 7354 | ||||||
| 2020-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-20-036783 | 7355 | ||||||
| 2020-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-20-036782 | 7242 | ||||||
| 2020-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-20-036780 | 7314 | ||||||
| 2020-06-11 | S-8 | S-8 | 0001193125-20-166765 | 333-239103 | 20957977 | 33 | 217239 | |||
| 2020-06-11 | 8-K | 8-K | 5.07 | 0001193125-20-166634 | 001-34186 | 20957228 | 34 | 166890 | 1 | 1 |
| 2020-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-033491 | 8682 | ||||||
| 2020-05-29 | 4 | FORM 4 SUBMISSION | 0001209191-20-032896 | 9221 | ||||||
| 2020-05-26 | DEFA14A | DEFA14A | 0001347178-20-000019 | 001-34186 | 20908109 | 34 | 72271 | |||
| 2020-05-26 | 8-K | 8-K | 8.01,9.01 | 0001347178-20-000018 | 001-34186 | 20908105 | 34 | 240139 | 1 | 1 |
| 2020-05-13 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-141074 | 001-34186 | 20871047 | 34 | 166587 | 1 | 1 |
| 2020-05-07 | 10-Q | 10-Q | 0001347178-20-000013 | 001-34186 | 20854503 | 34 | 5687057 | 1 | 1 | |
| 2020-05-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-20-134914 | 001-34186 | 20852825 | 34 | 244455 | 1 | 1 |
| 2020-04-24 | CT ORDER | filename1.pdf | 20200424,20200424 | 9999999997-20-002129 | 001-34186 | 20815620 | 34 | 125794 | ||
| 2020-04-22 | DEFA14A | DEFA14A | 0001347178-20-000010 | 001-34186 | 20808031 | 34 | 716587 | |||
| 2020-04-22 | DEF 14A | DEF 14A | 0001347178-20-000009 | 001-34186 | 20808013 | 34 | 2889362 | |||
| 2020-03-24 | 3 | FORM 3 SUBMISSION | 0001209191-20-020912 | 12764 | ||||||
| 2020-03-13 | 8-K | 8-K | 8.01 | 0001193125-20-073086 | 001-34186 | 20713932 | 34 | 146300 | 1 | 1 |
| 2020-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-20-016210 | 7204 | ||||||
| 2020-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-20-016208 | 5598 | ||||||
| 2020-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-20-016204 | 7688 | ||||||
| 2020-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-20-016200 | 7723 | ||||||
| 2020-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-20-016197 | 7683 | ||||||
| 2020-03-03 | 8-K | 8-K | 5.02 | 0001193125-20-060483 | 001-34186 | 20682779 | 34 | 177324 | 1 | 1 |
| 2020-02-28 | 4 | FORM 4 SUBMISSION | 0001209191-20-014132 | 7694 | ||||||
| 2020-02-28 | 4 | FORM 4 SUBMISSION | 0001209191-20-014129 | 7666 | ||||||
| 2020-02-28 | 4 | FORM 4 SUBMISSION | 0001209191-20-014127 | 7641 | ||||||
| 2020-02-28 | 4 | FORM 4 SUBMISSION | 0001209191-20-014126 | 7670 | ||||||
| 2020-02-28 | 4 | FORM 4 SUBMISSION | 0001209191-20-014124 | 7633 | ||||||
| 2020-02-26 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-049300 | 001-34186 | 20653416 | 34 | 911501 | 1 | 1 |
| 2020-02-26 | 10-K | 10-K | 0001347178-20-000003 | 001-34186 | 20653273 | 34 | 10918203 | 1 | 1 | |
| 2020-02-25 | 8-K | 8-K | 2.02,9.01 | 0001193125-20-048323 | 001-34186 | 20650649 | 34 | 254850 | 1 | 1 |
| 2020-02-20 | 8-K | 8-K | 5.02 | 0001193125-20-043567 | 001-34186 | 20635601 | 34 | 148372 | 1 | 1 |
| 2020-02-19 | 4 | FORM 4 SUBMISSION | 0001209191-20-010516 | 5601 | ||||||
| 2020-02-19 | 3 | FORM 3 SUBMISSION | 0001209191-20-010513 | 3575 | ||||||
| 2020-02-19 | 8-K | 8-K | 5.02,9.01 | 0001193125-20-041266 | 001-34186 | 20627378 | 34 | 172563 | 1 | 1 |
| 2020-02-14 | SC 13G/A | CONSONANCE CAPITAL MANAGEMENT LP | 0001085146-20-000850 | 005-82196 | 20619211 | 34 | 55055 | |||
| 2020-02-14 | SC 13G/A | Vanda_13G_A8.txt | 0001306923-20-000012 | 005-82196 | 20618597 | 34 | 111618 | |||
| 2020-02-14 | SC 13G/A | d8477782_13g-a.htm | 0000919574-20-001427 | 005-82196 | 20615736 | 34 | 111804 | |||
| 2020-02-13 | SC 13G/A | SC 13G/A | 0001193125-20-035671 | 005-82196 | 20611346 | 34 | 126730 | |||
| 2020-02-12 | SC 13G | vnda-13g_20191231.txt | 0001037389-20-000046 | 005-82196 | 20603138 | 34 | 13361 | |||
| 2020-02-12 | SC 13G/A | SCHEDULE 13G/A | 0001104659-20-018247 | 005-82196 | 20600505 | 34 | 13702 | |||
| 2020-02-04 | SC 13G/A | us9216591084_020320.txt | 0000834237-20-002791 | 005-82196 | 20572246 | 34 | 13255 | |||
| 2020-02-03 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-022109 | 001-34186 | 20566883 | 34 | 163294 | 1 | 1 |
| 2020-01-21 | 8-K | 8-K | 5.02 | 0001193125-20-011029 | 001-34186 | 20536485 | 34 | 145892 | 1 | 1 |
| 2020-01-13 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-006403 | 001-34186 | 20524365 | 34 | 172480 | 1 | 1 |
| 2020-01-06 | 4 | FORM 4 SUBMISSION | 0001209191-20-002032 | 5590 |
One latest value per concept from companyfacts (424 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 60.47M | 2026-10-22 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 268.70M | 2025-06-30 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| ecd | CoSelectedMeasureAmt | CoSelectedMeasureAmt | USD | 216.10M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001628280-26-026893 | ||
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 2.42M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001628280-26-026893 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 1.44M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001628280-26-026893 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 120 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001628280-26-026893 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 7.63M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001628280-26-026893 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 3.85M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001628280-26-026893 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 67 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001628280-26-026893 | ||
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 60.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | AccountsPayableAndOtherAccruedLiabilitiesCurrent | Accounts Payable and Other Accrued Liabilities, Current | USD | 7.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 1.63M | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-07-31 | 0001193125-15-271844 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 60.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | -117,000 | 2012-01-01 | 2012-03-31 | 2012 | Q1 | 10-Q | 2012-05-09 | 0001193125-12-220200 |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 127,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-02-26 | 0001193125-13-075214 | |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 0 | 2011-12-31 | 2011 | FY | 10-K | 2012-03-09 | 0001193125-12-105284 | |
| us-gaap | AccruedInvestmentIncomeReceivable | Accrued Investment Income Receivable | USD | 99,000 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-08 | 0001193125-14-188616 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 43.56M | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-07-31 | 0001193125-15-271844 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 43.56M | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-07-31 | 0001193125-15-271844 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 11.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | AccruedRoyaltiesCurrent | Accrued Royalties, Current | USD | 2.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 12.62M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax | USD | -108,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax | USD | 42,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -66,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 728.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation | USD | 283,000 | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001193125-18-046425 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 2.34M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation | USD | 1.63M | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-02-26 | 0001193125-13-075214 |
| us-gaap | AdvertisingExpense | Advertising Expense | USD | 28.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 7.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | AllowanceForDoubtfulAccountsReceivableCurrent | Accounts Receivable, Allowance for Credit Loss, Current | USD | 0 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 | |
| us-gaap | AllowanceForFundsUsedDuringConstructionInvestingActivities | Allowance for Funds Used During Construction, Investing Activities | USD | 1.90M | 2012-01-01 | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-03 | 0001193125-12-333283 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 5.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 6.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | Assets | Assets | USD | 382.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 238.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 78.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 5,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 100,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 384.47M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001628280-22-020848 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 100.91M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-17 | 0001193125-17-047317 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 31.62M | 2012-12-31 | 2013 | Q3 | 10-Q | 2013-11-08 | 0001193125-13-433952 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 382.63M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001628280-22-020848 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 382.63M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001628280-22-020848 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 61.83M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001347178-19-000017 | |
| us-gaap | AvailableForSaleSecuritiesFairValueDisclosure | Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) | USD | 1.00M | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-10 | 0001193125-13-212435 | |
| us-gaap | AvailableforsaleSecuritiesGrossUnrealizedGain | Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) | USD | 10,000 | 2012-12-31 | 2013 | Q1 | 10-Q | 2013-05-10 | 0001193125-13-212435 | |
| us-gaap | AvailableForSaleSecuritiesGrossUnrealizedLosses1 | Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) | USD | 20,000 | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-03 | 0001193125-12-333283 | |
| us-gaap | BusinessAcquisitionCostOfAcquiredEntityTransactionCosts | Business Acquisition, Transaction Costs | USD | 600,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 | |
| us-gaap | BusinessAcquisitionProFormaEarningsPerShareBasic | Business Acquisition, Pro Forma Earnings Per Share, Basic | USD/shares | -2.9 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 |
| us-gaap | BusinessAcquisitionProFormaEarningsPerShareDiluted | Business Acquisition, Pro Forma Earnings Per Share, Diluted | USD/shares | -2.9 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 |
| us-gaap | BusinessAcquisitionsProFormaNetIncomeLoss | Business Acquisition, Pro Forma Net Income (Loss) | USD | -100.74M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 |
| us-gaap | BusinessAcquisitionsProFormaRevenue | Business Acquisition, Pro Forma Revenue | USD | 79.33M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets | USD | 18.99M | 2014-12-31 | 2016 | FY | 10-K | 2017-02-17 | 0001193125-17-047317 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets | USD | 91,000 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-17 | 0001193125-17-047317 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles | USD | 15.94M | 2014-12-31 | 2016 | FY | 10-K | 2017-02-17 | 0001193125-17-047317 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory | USD | 2.96M | 2014-12-31 | 2016 | FY | 10-K | 2017-02-17 | 0001193125-17-047317 | |
| us-gaap | BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses | Business Combination, Separately Recognized Transactions, Net Gains and Losses | USD | 59.53M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 61.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -6.80M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001193125-18-046425 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 62.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -23.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 150.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 60.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 60.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 60,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -134.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | ContractualObligation | Contractual Obligation | USD | 30.27M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-19 | 0001347178-19-000003 | |
| us-gaap | ContractualObligationDueAfterFifthYear | Contractual Obligation, to be Paid, after Year Five | USD | 10.67M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-19 | 0001347178-19-000003 | |
| us-gaap | ContractualObligationDueInFifthYear | Contractual Obligation, to be Paid, Year Five | USD | 2.42M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-19 | 0001347178-19-000003 | |
| us-gaap | ContractualObligationDueInFourthYear | Contractual Obligation, to be Paid, Year Four | USD | 2.81M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-19 | 0001347178-19-000003 | |
| us-gaap | ContractualObligationDueInNextTwelveMonths | Contractual Obligation, to be Paid, Year One | USD | 7.80M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-19 | 0001347178-19-000003 | |
| us-gaap | ContractualObligationDueInSecondYear | Contractual Obligation, to be Paid, Year Two | USD | 3.34M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-19 | 0001347178-19-000003 | |
| us-gaap | ContractualObligationDueInThirdYear | Contractual Obligation, to be Paid, Year Three | USD | 3.23M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-19 | 0001347178-19-000003 | |
| us-gaap | ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear | Contractual Obligation, to be Paid, Remainder of Fiscal Year | USD | 796,000 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001347178-18-000010 | |
| us-gaap | ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice | Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price | USD | 800,000 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-10-30 | 0001628280-25-047317 |
| us-gaap | ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress | Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress | USD | 3.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | ContractWithCustomerRefundLiability | Contract with Customer, Refund Liability | USD | 25.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization | Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | USD | 10.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | CostOfGoodsSold | Cost of Goods Sold (Deprecated 2018-01-31) | USD | 19.44M | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-03 | 0001193125-16-757991 |
| us-gaap | CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization | Cost of Goods Sold, Excluding Depreciation, Depletion, and Amortization (Deprecated 2019-01-31) | USD | 24.49M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001347178-20-000003 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 309.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 55,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 143,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 185,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent | DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent | USD | 78.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent | DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent | USD | 78.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGainLoss | Debt Securities, Available-for-sale, Realized Gain (Loss) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | DeferredCostsCurrentAndNoncurrent | Deferred Costs | USD | 252,000 | 2014-12-31 | 2015 | FY | 10-K | 2016-02-12 | 0001193125-16-461076 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 78.68M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | 38,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | DeferredIncomeTaxAssetsNet | Deferred Income Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 2.85M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | DeferredRentCreditCurrent | Deferred Rent Credit, Current | USD | 247,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 3.10M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 90.28M | 2013-12-31 | 2016 | FY | 10-K | 2017-02-17 | 0001193125-17-047317 | |
| us-gaap | DeferredRevenueAdditions | Deferred Revenue, Additions | USD | 314,000 | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-07-31 | 0001193125-15-271844 |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 174,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 63.49M | 2013-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 | |
| us-gaap | DeferredRevenueRevenueRecognized | Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) | USD | 30.75M | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-02-12 | 0001193125-16-461076 |
| us-gaap | DeferredRevenueRevenueRecognized1 | Deferred Revenue, Revenue Recognized | USD | 30.75M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-17 | 0001193125-17-047317 |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 2.72M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | DeferredTaxAssetsCharitableContributionCarryforwards | Deferred Tax Assets, Charitable Contribution Carryforwards | USD | 420,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 | |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 36.67M | 2013-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 1.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 127.25M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 100,000 | 2016-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001193125-18-046425 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNetNoncurrent | Deferred Tax Assets, Net, Noncurrent | USD | 89.07M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001347178-19-000017 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | DeferredTaxAssetsNetCurrent | Deferred Tax Assets, Net of Valuation Allowance, Current | USD | 0 | 2011-12-31 | 2011 | FY | 10-K | 2012-03-09 | 0001193125-12-105284 | |
| us-gaap | DeferredTaxAssetsNetNoncurrent | Deferred Tax Assets, Net of Valuation Allowance, Noncurrent | USD | 0 | 2011-12-31 | 2011 | FY | 10-K | 2012-03-09 | 0001193125-12-105284 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 22.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 13.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 8.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 86,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsOther | Deferred Tax Assets, Tax Credit Carryforwards, Other | USD | 18.60M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 20.60M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | USD | 3.31M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseOther | Deferred Tax Assets, Tax Deferred Expense, Other | USD | 6.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 2.43M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts | USD | 2.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 124.40M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 15,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001347178-20-000003 | |
| us-gaap | DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets | Deferred Tax Liabilities, Intangible Assets | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 2.85M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities | Deferred Tax Liabilities, Unrealized Gains on Trading Securities | USD | 6,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 1.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercent | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay | pure | 0.5 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-02-26 | 0001193125-13-075214 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 0.5 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent (Deprecated 2013-01-31) | pure | 0.06 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-02-26 | 0001193125-13-075214 |
| us-gaap | DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | pure | 0.06 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | Depreciation | Depreciation | USD | 783,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 420,000 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-04 | 0001193125-15-365182 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -2.23 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.04 | 2017-10-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-02-19 | 0001347178-19-000003 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -2.23 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0.59 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.775 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | USD | -4,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent | pure | -0.009 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.007 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.045 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0001628280-25-005761 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | 400,000 | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-07 | 0001347178-20-000013 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.071 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0001628280-25-005761 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.017 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | -0.008 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsOther | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent | pure | -0.006 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.018 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxSettlements | Effective Income Tax Rate Reconciliation, Tax Settlement, Percent | pure | -0.001 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0001628280-25-005761 |
| us-gaap | EffectOfExchangeRateOnCashAndCashEquivalents | Effect of Exchange Rate on Cash and Cash Equivalents | USD | 40,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001193125-18-046425 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | -42,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 9.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions | Employee Service Share-based Compensation, Cash Received from Exercise of Stock Options (Deprecated 2017-01-31) | USD | 2.21M | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-03 | 0001193125-17-154971 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions | Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount | USD | 2.40M | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-08 | 0001193125-13-433952 | |
| us-gaap | ExcessTaxBenefitFromShareBasedCompensationFinancingActivities | Excess Tax Benefit from Share-based Compensation, Financing Activities | USD | 2.89M | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-02-26 | 0001193125-13-075214 |
| us-gaap | ExcessTaxBenefitFromShareBasedCompensationOperatingActivities | Excess Tax Benefit from Share-based Compensation, Operating Activities | USD | 2.89M | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-02-26 | 0001193125-13-075214 |
| us-gaap | FinanceLeaseInterestExpense | Finance Lease, Interest Expense | USD | 343,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | FinanceLeaseInterestPaymentOnLiability | Finance Lease, Interest Payment on Liability | USD | 343,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | FinanceLeaseLiability | Finance Lease, Liability | USD | 7.48M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 4.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 2.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDue | Finance Lease, Liability, Payment, Due | USD | 8.08M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueAfterYearFive | Finance Lease, Liability, to be Paid, after Year Five | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0001628280-25-005761 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueNextTwelveMonths | Finance Lease, Liability, to be Paid, Year One | USD | 3.52M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearFive | Finance Lease, Liability, to be Paid, Year Five | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0001628280-25-005761 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearFour | Finance Lease, Liability, to be Paid, Year Four | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0001628280-25-005761 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearThree | Finance Lease, Liability, to be Paid, Year Three | USD | 1.22M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearTwo | Finance Lease, Liability, to be Paid, Year Two | USD | 3.34M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | FinanceLeaseLiabilityUndiscountedExcessAmount | Finance Lease, Liability, Undiscounted Excess Amount | USD | 601,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 2.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | FinanceLeaseRightOfUseAsset | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | USD | 5.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | FinanceLeaseRightOfUseAssetAmortization | Finance Lease, Right-of-Use Asset, Amortization | USD | 2.11M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | FinanceLeaseWeightedAverageDiscountRatePercent | Finance Lease, Weighted Average Discount Rate, Percent | pure | 0.062 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 36.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive | Finite-Lived Intangible Asset, Expected Amortization, after Year Five | USD | 77.35M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | Finite-Lived Intangible Asset, Expected Amortization, Year One | USD | 7.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year | USD | 1.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFive | Finite-Lived Intangible Asset, Expected Amortization, Year Five | USD | 7.95M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | Finite-Lived Intangible Asset, Expected Amortization, Year Four | USD | 7.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | Finite-Lived Intangible Asset, Expected Amortization, Year Three | USD | 7.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | Finite-Lived Intangible Asset, Expected Amortization, Year Two | USD | 7.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | FiniteLivedIntangibleAssetsGross | Finite-Lived Intangible Assets, Gross | USD | 147.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 111.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | GainLossOnContractTermination | Gain (Loss) on Contract Termination | USD | -700,000 | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-02-25 | 0001193125-14-066051 |
| us-gaap | GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | USD | 23,000 | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-02-26 | 0001193125-13-075214 |
| us-gaap | GainLossRelatedToLitigationSettlement | Gain (Loss) Related to Litigation Settlement | USD | 77.62M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-17 | 0001193125-17-047317 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 24.59M | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-02-25 | 0001193125-14-066051 |
| us-gaap | GrossProfit | Gross Profit | USD | 60.87M | 2020-10-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-11 | 0001347178-21-000005 |
| us-gaap | ImpairmentOfIntangibleAssetsExcludingGoodwill | Impairment of Intangible Assets (Excluding Goodwill) | USD | 0 | 2012-01-01 | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-03 | 0001193125-12-333283 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -138.91M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -133.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 261,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | 23.03M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-07-29 | 0001347178-21-000028 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | -90,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 446,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | IncomeTaxExpenseBenefitContinuingOperations | Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) | USD | -400,000 | 2011-01-01 | 2011-12-31 | 2012 | FY | 10-K | 2013-02-26 | 0001193125-13-075214 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 140,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | IncomeTaxPaidForeignAfterRefundReceived | IncomeTaxPaidForeignAfterRefundReceived | USD | 64,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 107.49M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 126,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -29.12M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount | USD | 1.24M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 121,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 968,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | IncomeTaxReconciliationOtherReconcilingItems | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount | USD | 900,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 2.41M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 1.06M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | IncomeTaxReconciliationTaxCreditsOther | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount | USD | 775,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 2.49M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 796,000 | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-07-31 | 0001193125-15-271844 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 1.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities | Increase (Decrease) in Accounts Payable and Other Operating Liabilities | USD | 5.95M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001193125-18-046425 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 5.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | IncreaseDecreaseInAccruedIncomeTaxesPayable | Increase (Decrease) in Income Taxes Payable | USD | -2.27M | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-02-25 | 0001193125-14-066051 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 24.39M | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-07 | 0001193125-15-177216 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 36.19M | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-07-31 | 0001193125-15-271844 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -30.57M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-17 | 0001193125-17-047317 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | -330,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 28,000 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | 267,000 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 8.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | IncreaseDecreaseInRestrictedCash | Increase (Decrease) in Restricted Cash | USD | 46,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-17 | 0001193125-17-047317 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 618,229 | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-02-26 | 0001193125-13-075214 |
| us-gaap | InventoryFinishedGoodsNetOfReserves | Inventory, Finished Goods, Net of Reserves | USD | 1.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 1.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | InventoryNoncurrent | Inventory, Noncurrent | USD | 8.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | InventoryRawMaterialsNetOfReserves | Inventory, Raw Materials, Net of Reserves | USD | 198,000 | 2014-12-31 | 2015 | FY | 10-K | 2016-02-12 | 0001193125-16-461076 | |
| us-gaap | InventoryWorkInProcessNetOfReserves | Inventory, Work in Process, Net of Reserves | USD | 33,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 461,000 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-03-09 | 0001193125-12-105284 |
| us-gaap | InvestmentIncomeNetAmortizationOfDiscountAndPremium | Investment Income, Net, Amortization of Discount and Premium | USD | 208,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 3.60M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-11 | 0001347178-21-000005 |
| us-gaap | LeaseCost | Lease, Cost | USD | 5.13M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 5.67M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0001628280-25-005761 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 2.41M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0001628280-25-005761 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 1.10M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0001628280-25-005761 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 1.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 2.16M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 633,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001347178-19-000017 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 527,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | Liabilities | Liabilities | USD | 182.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 382.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 154.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | LiabilityForUncertainTaxPositionsCurrent | Liability for Uncertainty in Income Taxes, Current | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-19 | 0001347178-19-000003 | |
| us-gaap | LicenseAndServicesRevenue | License and Services Revenue (Deprecated 2018-01-31) | USD | 20.04M | 2013-01-01 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-08 | 0001193125-13-433952 |
| us-gaap | LicenseCosts | License Costs (Deprecated 2018-01-31) | USD | 1.00M | 2012-01-01 | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-03 | 0001193125-12-333283 |
| us-gaap | LicensesRevenue | Licenses Revenue (Deprecated 2018-01-31) | USD | 30.75M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-17 | 0001193125-17-047317 |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | -16,000 | 2012-01-01 | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-03 | 0001193125-12-333283 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | -2.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 3.59M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-01 | 0001347178-19-000014 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 89.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -48.20M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-01 | 0001347178-19-000014 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -109.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | 30.16M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-01 | 0001347178-19-000014 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -133.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 | Noncash or Part Noncash Acquisition, Fixed Assets Acquired | USD | 200,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-19 | 0001347178-19-000003 |
| us-gaap | NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 | Noncash or Part Noncash Acquisition, Intangible Assets Acquired | USD | 25.00M | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-04 | 0001193125-15-365182 |
| us-gaap | NoncashOrPartNoncashAcquisitionInventoryAcquired1 | Noncash or Part Noncash Acquisition, Inventory Acquired | USD | 3.00M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-17 | 0001193125-17-047317 |
| us-gaap | NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1 | Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) | USD | 25.00M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001193125-18-046425 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -137.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 2.23M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 5.14M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 655,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 14.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 2.81M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 14.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 22.76M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001347178-20-000003 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 2.48M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001347178-20-000003 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 2.42M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001347178-20-000003 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 2.35M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001347178-20-000003 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 2.33M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001347178-20-000003 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 2.50M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001347178-20-000003 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 10.67M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001347178-20-000003 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 599,000 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001347178-18-000010 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.082 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 228.00M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-17 | 0001193125-17-047317 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 1.05M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-11 | 0001347178-21-000005 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 2.71M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001193125-18-046425 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 28,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 | |
| us-gaap | OtherCommitment | Other Commitment | USD | 200,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-19 | 0001347178-19-000003 | |
| us-gaap | OtherCommitmentDueAfterFifthYear | Other Commitment, to be Paid, after Year Five | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-19 | 0001347178-19-000003 | |
| us-gaap | OtherCommitmentDueInFifthYear | Other Commitment, to be Paid, Year Five | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-19 | 0001347178-19-000003 | |
| us-gaap | OtherCommitmentDueInFourthYear | Other Commitment, to be Paid, Year Four | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-19 | 0001347178-19-000003 | |
| us-gaap | OtherCommitmentDueInNextTwelveMonths | Other Commitment, to be Paid, Year One | USD | 200,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-19 | 0001347178-19-000003 | |
| us-gaap | OtherCommitmentDueInSecondYear | Other Commitment, to be Paid, Year Two | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-19 | 0001347178-19-000003 | |
| us-gaap | OtherCommitmentDueInThirdYear | Other Commitment, to be Paid, Year Three | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-19 | 0001347178-19-000003 | |
| us-gaap | OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear | Other Commitment, to be Paid, Remainder of Fiscal Year | USD | 2.00M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-02 | 0001347178-18-000007 | |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent | USD | -26,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax | USD | -669,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecrease | Other Comprehensive Income (Loss), before Tax (Deprecated 2012-01-31) | USD | -7.96M | 2012-01-01 | 2012-03-31 | 2012 | Q1 | 10-Q | 2012-05-09 | 0001193125-12-220200 |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax | USD | 25,000 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-08 | 0001628280-25-023448 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | 555,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) | USD | 6,000 | 2012-01-01 | 2012-03-31 | 2012 | Q1 | 10-Q | 2012-05-09 | 0001193125-12-220200 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | -695,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | OtherComprehensiveIncomeLossTax | Other Comprehensive Income (Loss), Tax | USD | 91,000 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-08 | 0001628280-25-023448 |
| us-gaap | OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 | Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax | USD | 6,000 | 2012-01-01 | 2012-03-31 | 2012 | Q1 | 10-Q | 2012-05-09 | 0001193125-12-220200 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | 83,000 | 2011-01-01 | 2011-06-30 | 2011 | Q2 | 10-Q | 2011-08-05 | 0000950123-11-073247 |
| us-gaap | OtherIncome | Other Income | USD | 4.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 28,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 10.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -1.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 4.76M | 2015-12-31 | 2015 | FY | 10-K | 2016-02-12 | 0001193125-16-461076 | |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 116,000 | 2011-12-31 | 2012 | FY | 10-K | 2013-02-26 | 0001193125-13-075214 | |
| us-gaap | PaymentsForProceedsFromOtherInvestingActivities | Payments for (Proceeds from) Other Investing Activities | USD | -124,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001193125-18-046425 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 384,000 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-02-25 | 0001193125-14-066051 |
| us-gaap | PaymentsForTenantImprovements | Payments for Tenant Improvements | USD | -1.82M | 2012-01-01 | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-03 | 0001193125-12-333283 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | PaymentsToAcquireIntangibleAssets | Payments to Acquire Intangible Assets | USD | 10.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | PaymentsToAcquireLeaseReceivables | Payments to Acquire Lease Receivables | USD | 1.60M | 2012-04-01 | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-03 | 0001193125-12-333283 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 722,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 20.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 36.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 423,000 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-12 | 0001193125-16-461076 | |
| us-gaap | PrepaidRent | Prepaid Rent | USD | 32,000 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-08 | 0001193125-14-188616 | |
| us-gaap | PrepaidRoyalties | Prepaid Royalties | USD | 1.76M | 2016-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001193125-18-046425 | |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-11 | 0001347178-21-000005 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 77.33M | 2012-01-01 | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-03 | 0001193125-12-333283 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 99.97M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecurities | Proceeds from Sale of Available-for-sale Securities | USD | 999,000 | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001193125-18-046425 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 66,000 | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-02-26 | 0001193125-13-075214 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0001628280-25-005761 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 14.86M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 3.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | ProvisionForDoubtfulAccounts | Accounts Receivable, Credit Loss Expense (Reversal) | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 |
| us-gaap | PurchaseObligation | Purchase Obligation | USD | 12.87M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001347178-19-000017 | |
| us-gaap | PurchaseObligationDueAfterFifthYear | Purchase Obligation, to be Paid, after Year Five | USD | 0 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001347178-19-000017 | |
| us-gaap | PurchaseObligationDueInFifthYear | Purchase Obligation, to be Paid, Year Five | USD | 0 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001347178-19-000017 | |
| us-gaap | PurchaseObligationDueInFourthYear | Purchase Obligation, to be Paid, Year Four | USD | 2.60M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | PurchaseObligationDueInNextTwelveMonths | Purchase Obligation, to be Paid, Year One | USD | 12.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | PurchaseObligationDueInSecondYear | Purchase Obligation, to be Paid, Year Two | USD | 7.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | PurchaseObligationDueInThirdYear | Purchase Obligation, to be Paid, Year Three | USD | 2.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear | Purchase Obligation, to be Paid, Remainder of Fiscal Year | USD | 3.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 93.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 469,000 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-07-31 | 0001628280-25-036861 | |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 365,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 10,000 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-02-25 | 0001193125-14-066051 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 59,000 | 2013-12-31 | 2013 | FY | 10-K | 2014-02-25 | 0001193125-14-066051 | |
| us-gaap | RestructuringReserveAccrualAdjustment | Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) | USD | -54,000 | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-08 | 0001193125-12-458846 |
| us-gaap | RestructuringReserveSettledWithCash | Restructuring Reserve, Settled With Cash (Deprecated 2013-01-31) | USD | 264,000 | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-10 | 0001193125-13-212435 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -528.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 172.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | RevenueFromGrants | Revenue from Grants (Deprecated 2018-01-31) | USD | 489,000 | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-02-26 | 0001193125-13-075214 |
| us-gaap | RevenueRecognitionMilestoneMethodRevenueRecognized | Revenue Recognition, Milestone Method, Revenue Recognized | USD | 2.80M | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-08 | 0001193125-12-458846 |
| us-gaap | Revenues | Revenues | USD | 172.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | USD | 1.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 10.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | RoyaltyRevenue | Royalty Revenue (Deprecated 2018-01-31) | USD | 6.50M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-17 | 0001193125-17-047317 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 11.6 | 2014-10-31 | 2016 | FY | 10-K | 2017-02-17 | 0001193125-17-047317 | |
| us-gaap | SalesRevenueGoodsNet | Sales Revenue, Goods, Net (Deprecated 2018-01-31) | USD | 140.08M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001347178-18-000010 |
| us-gaap | SalesRevenueNet | Revenue, Net (Deprecated 2018-01-31) | USD | 25.10M | 2013-01-01 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-08 | 0001193125-13-433952 |
| us-gaap | SecurityDeposit | Security Deposit | USD | 500,000 | 2011-07-04 | 2012 | Q3 | 10-Q | 2012-11-08 | 0001193125-12-458846 | |
| us-gaap | SecurityDepositLiability | Security Deposit Liability | USD | 500,000 | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-03 | 0001193125-12-333283 | |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 199.77M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 7.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | USD/shares | 7.74 | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-08 | 0001193125-12-458846 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 32,000 | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-08 | 0001193125-12-458846 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 4.3 | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-08 | 0001193125-12-458846 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 492,376 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-08 | 0001193125-12-458846 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 7.19 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-08 | 0001193125-12-458846 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | USD | 1.80M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-12 | 0001193125-16-461076 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.045 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.011 | 2012-01-01 | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-03 | 0001193125-12-333283 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate | pure | 0.5 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 5.07M | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-05 | 0001193125-16-578637 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 4.44M | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-05 | 0001193125-16-578637 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 12.02 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-05 | 0001193125-16-578637 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 545,104 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001347178-20-000024 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 172,735 | 2016-01-01 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-05 | 0001193125-16-578637 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 2.95 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 5.87M | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-05 | 0001193125-16-578637 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 6.82M | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-05 | 0001193125-16-578637 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 11.46 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-05 | 0001193125-16-578637 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 5.82M | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-05 | 0001193125-16-578637 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 6.59M | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-05 | 0001193125-16-578637 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 11.52 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-05 | 0001193125-16-578637 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 3.82 | 2016-01-01 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-05 | 0001193125-16-578637 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 14.29 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001347178-20-000024 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 11.16 | 2016-01-01 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-05 | 0001193125-16-578637 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 7.94 | 2016-01-01 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-05 | 0001193125-16-578637 |
| us-gaap | SharesPaidForTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation | shares | 32,386 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 451,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 199.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 5.75M | 2014-10-01 | 2014-10-31 | 2016 | FY | 10-K | 2017-02-17 | 0001193125-17-047317 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 100.87M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-11 | 0001347178-21-000005 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | Supplies | Prepaid Supplies | USD | 346,000 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-07 | 0001193125-15-177216 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 19.57M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 159,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 796,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 87,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations | USD | 104,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 19.60M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 | |
| us-gaap | UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount | Unrecorded Unconditional Purchase Obligation | USD | 1.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | -12.30M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091300 |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007460 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 60.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 44.74M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001193125-18-046425 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 60.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001347178-26-000002 |